Exelixis EXEL Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exelixis's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exelixis's share buybacks?
- Exelixis (EXEL) reported share buybacks of $430.35M in Q1 2026.
- How has Exelixis's share buybacks changed year-over-year?
- Exelixis's share buybacks increased by 51.6% year-over-year, from $283.93M to $430.35M.
- What does share buybacks mean?
- Cash spent by the company to buy back its own stock.
- How do you interpret share buybacks?
- Repurchases often signal management's confidence in the company's valuation and a commitment to increasing earnings per share for remaining shareholders.
- How does share buybacks compare across companies?
- A common capital return strategy for mature biopharma companies with strong cash flows; peers vary based on their specific capital return policies.